Laurion Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-199,066	Closed	-$2.89M	–	461
2023 Q1	$2.89M	Hold	199,066	–	–	0.02%	92
2022 Q4	$2.69M	Hold	199,066	–	–	0.01%	102
2022 Q3	$3.14M	Buy	199,066 +70,000	+54%	+$1.1M	0.02%	108
2022 Q2	$1.57M	Buy	+129,066	New	+$1.57M	0.02%	135